Apimeds Pharmaceuticals US, Inc. (APUS) is a publicly traded Healthcare sector company. As of September 25, 2026, APUS trades at $6.68 with a market cap of $3.46M and a P/E ratio of -9.30. APUS moved +37.43% today. Year to date, APUS is -77.64%; over the trailing twelve months it is -74.57%. Its 52-week range spans $1.51 to $59.70. Rallies surfaces APUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for APUS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $6.68 |
| Market Cap | $3.46M |
| P/E Ratio | -9.30 |
| EPS | $-0.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $59.70 |
| 52-Week Low | $1.51 |
| Volume | 33.19M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.00M |
| Gross Margin | 0.00% |
APUS analyst coverage data. Average price target: $0.00.